Please login to the form below
The Editors blog
An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team
Brand DNA: decoding the next generation
11 Feb 2013
Of the key drivers that will chart your brand’s success, one may be the hot button of the future
Food for thought16 Jan 2013
To win in 2013 and beyond pharma companies will need to focus on three basic principles
A few brief thoughts on partnerships20 Dec 2012
How working together is gaining importance in the pharma industry
An introduction to the QiC Programme10 Dec 2012
One of PMGroup's newer projects, QiC focuses on sharing good practice in healthcare
-
Smart innovation and European healthcare
16 Nov 2012
Plans are afoot to improve six key areas of healthcare for Europe’s ageing population
Five things that have changed on PMLiVE (and one that’s not)09 Nov 2012
New pharma blogs, a people section and a unique company resource
-
PMLiVE: revitalised and refreshed
08 Nov 2012
A 'beta' phase unveiling for our website's new look
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- Environment: where does the pharmaceutical industry stand?
- ONS data reveals significant decrease in COVID-19 antibodies
- Novartis reports death of two patients treated with Zolgensma
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Are we the masters or servants of omnichannel engagement?
- JCVI publishes advice on COVID-19 vaccines ahead of autumn booster campaign
- AstraZeneca and Daiichi Sankyo’s Enhertu shows significant improvement for breast cancer patients
- Gilead Sciences announce positive results for Trodelvy in breast cancer patients
- UK government to launch national mission to tackle dementia
- WHO publishes first position paper on optimising brain health
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- Sanofi halts recruitment for trials assessing MS treatment
- Environment: where does the pharmaceutical industry stand?
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Avastin wins EU approval for advanced renal cancer
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
